Published • loading... • Updated
Nearly Half of Infertility Cases Involve Men, Yet Most Skip Testing. PS Fertility Wants to Close the Gap.
The non-invasive PS Detect test measures sperm competency and is backed by $3.5 million in Series A funding, the company said.
- PS Fertility launched PS Detect, a non-invasive at-home test measuring sperm competency, backed by $3.5 million in Series A funding on Thursday.
- Nearly 50% of infertility cases involve a male factor, yet male testing remains underdiagnosed and often overlooked in clinical evaluations despite affecting 1 in 6 couples.
- Supported by a $1.7 million NIH grant, PS Detect measures sperm competency rather than count alone, offering clinicians a clearer diagnostic pathway for male patients.
- "For too long, the conversation about fertility has centered almost entirely on women," CEO Kevin Combs said, noting that excluding men from evaluations remains incomplete.
- Clinicians can normalize male testing during routine check-ups by framing it as proactive rather than diagnostic, helping men take control of their fertility future.
Insights by Ground AI
87 Articles
87 Articles
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources87
Leaning Left14Leaning Right6Center37Last UpdatedBias Distribution65% Center
Bias Distribution
- 65% of the sources are Center
65% Center
L 25%
C 65%
Factuality
To view factuality data please Upgrade to Premium
